chr3-10093893-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001018115.3(FANCD2):​c.3889-396A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.252 in 152,072 control chromosomes in the GnomAD database, including 6,642 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.25 ( 6642 hom., cov: 32)

Consequence

FANCD2
NM_001018115.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.231

Publications

23 publications found
Variant links:
Genes affected
FANCD2 (HGNC:3585): (FA complementation group D2) The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group D2. This protein is monoubiquinated in response to DNA damage, resulting in its localization to nuclear foci with other proteins (BRCA1 AND BRCA2) involved in homology-directed DNA repair. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
FANCD2OS (HGNC:28623): (FANCD2 opposite strand) This gene encodes a conserved protein of unknown function. [provided by RefSeq, Jan 2013]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.489 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001018115.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FANCD2
NM_001018115.3
MANE Select
c.3889-396A>G
intron
N/ANP_001018125.1Q9BXW9-2
FANCD2
NM_033084.6
c.3889-396A>G
intron
N/ANP_149075.2
FANCD2
NM_001374254.1
c.3850-396A>G
intron
N/ANP_001361183.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FANCD2
ENST00000675286.1
MANE Select
c.3889-396A>G
intron
N/AENSP00000502379.1Q9BXW9-2
FANCD2
ENST00000287647.7
TSL:1
c.3889-396A>G
intron
N/AENSP00000287647.3Q9BXW9-1
FANCD2
ENST00000419585.5
TSL:1
c.3889-396A>G
intron
N/AENSP00000398754.1Q9BXW9-2

Frequencies

GnomAD3 genomes
AF:
0.252
AC:
38234
AN:
151954
Hom.:
6630
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.495
Gnomad AMI
AF:
0.270
Gnomad AMR
AF:
0.177
Gnomad ASJ
AF:
0.151
Gnomad EAS
AF:
0.0896
Gnomad SAS
AF:
0.220
Gnomad FIN
AF:
0.116
Gnomad MID
AF:
0.155
Gnomad NFE
AF:
0.163
Gnomad OTH
AF:
0.213
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.252
AC:
38282
AN:
152072
Hom.:
6642
Cov.:
32
AF XY:
0.245
AC XY:
18256
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.495
AC:
20499
AN:
41422
American (AMR)
AF:
0.177
AC:
2705
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.151
AC:
523
AN:
3470
East Asian (EAS)
AF:
0.0894
AC:
463
AN:
5180
South Asian (SAS)
AF:
0.220
AC:
1061
AN:
4824
European-Finnish (FIN)
AF:
0.116
AC:
1227
AN:
10602
Middle Eastern (MID)
AF:
0.143
AC:
42
AN:
294
European-Non Finnish (NFE)
AF:
0.163
AC:
11069
AN:
67984
Other (OTH)
AF:
0.212
AC:
447
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1275
2549
3824
5098
6373
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
374
748
1122
1496
1870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.188
Hom.:
6049
Bravo
AF:
0.269
Asia WGS
AF:
0.159
AC:
554
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.29
DANN
Benign
0.46
PhyloP100
-0.23
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1552244; hg19: chr3-10135577; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.